Novotech ex­tends arms in­to US with ac­qui­si­tion of a South Car­oli­na CRO

The Sin­ga­pore-based CRO Novotech has ac­quired NCGS to ex­pand its glob­al of­fer­ings for clients, and fi­nal­ly of­fer its full-ser­vice high-qual­i­ty clin­i­cal ser­vices to cus­tomers in the US.

NCGS has been in Charleston, SC since 1984. The CRO has about 300 em­ploy­ees across the US and fo­cus­es on the clin­i­cal de­vel­op­ment of on­col­o­gy, hema­tol­ogy, in­fec­tious dis­ease and CNS in adults and chil­dren. On its web­site, it boasts of hav­ing 80 ap­proved prod­ucts and ze­ro Form 483s or FDA warn­ing let­ters.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER